# Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

> **NCT06643286** · NA · RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Melanoma (Skin)
- Melanoma, Stage II, Stage I
- Melanoma Stage
- Survivorship

## Interventions

- **DEVICE:** Digizorg Melanoma app

## Key facts

- **NCT ID:** NCT06643286
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-06-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06643286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06643286, "Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06643286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*